Tue, 09 Aug 2022 13:30:06 GMT
Pfizer buys Global Blood Therapeutics
Pfizer has announced that the company would pay $68.50 per share to acquire Global Blood Therapeutics. The company intends to use the cash made from COVID-19 products to invest in other sectors.